Remix Therapeutics

Clinical-stage biotechnology company developing small molecules that modulate RNA processing to treat cancer and other serious diseases. Their REMaster platform targets RNA splicing and processing to create novel therapeutics.

Location
Cambridge, Massachusetts, USA
Founded
2018
Investors
1
Categories
rna-therapeutics, biotech, therapeutics, small-molecule, oncology

Investors

NameLocationTypeStagesPortfolio
Alexandria Venture InvestmentsPasadena, USAcvc
seedseries-a+3
6